- The University of Texas at Arlington received $250,000 for ultrasensitive nanosensor-based detection of tumor immunogenic peptides to enable personalized cancer immunotherapy.
- The University of Texas at Austin received three grants:
- $249,999 for research into novel covalent drugs for BCL6
- $3,995,180 for research into advanced protein therapeutics core
- $249,932 for novel modulators of genomic instability in human cells
- Dallas-based University of Texas Southwestern Medical Center received four grants:
- $3 million to establish the Accelerating Clinical Oncology Research Network-Texas to enhance clinical trial access in North and Central Texas
- $4 million to establish new Cryo-EM core services to drive cancer research and drug discovery at UT Southwestern Medical Center
- $250,000 to develop a novel optogenetic recombinase system to study and target metastatic cancer
- $237,501 to research the impact of immunity on pre-malignant somatic mosaicism and cancer prevention
- Dallas-based Texas A&M University System Health Science Center received $237,500 for a glia-to-neuron conversion for treating oral cancer pain.
- Dallas-based ImmuneSensor Therapeutics received $16,154,562 for a phase 2 clinical trial to evaluate the safety and efficacy of IMSA101 in combination with radiotherapy and checkpoint inhibitors in solid tumor malignancies.
- The University of Texas Medical Branch at Galveston received $1,494,784 for hyperspectral, quantitative intraoperative fluorescence image-guided brain surgery.
- Houston-based University of Texas MD Anderson Cancer Center received five grants:
- $1.5 million for CPRIT Early Clinical Investigator Award to Christopher Alvarez-Breckenridge, MD, PhD
- $249,976 for reversing aging-associated resistance to cancer immunotherapy
- $249,999 for fasting-induced microbiome changes and radioprotection
- $250,000 for restoration of phagocytosis function of glioma-associated microglia/macrophage by activating QKI-PPARb-RXRa
- $250,000 for identification of enhancers of T-cell anti-tumor activity in PDAC using CRISPR activation screening
- Houston-based Methodist Hospital Research Institute received two grants:
- $250,000 for targeting NHE6 to improve clinical efficacy of daratumumab in myeloma
- $250,000 for targeting nitric oxide synthase pathway to remodel obesity-induced tumor inflammation in patients with TNBC
- Houston-based Baylor College of Medicine received two grants:
- $3,999,996 for Patient-Derived Xenograft and Advanced In vivo Models Core Facility of Texas
- $250,000 for targeting tumors and the tumor microenvironment with banana lectin-expressing T-cells
- Lubbock-based Texas Tech University received $249,999 for in vivo Akt analysis via chemical genetics and nanoparticle-mediated probe delivery.
- Lubbock-based Texas Tech University Health Sciences Center received $3,369,480 for West Texas Pharmacology Core.
- The University of Texas Health Science Center at San Antonio received two grants:
- $3,935,480 for Texas Pediatric Cancer Testing Core
- $3,998,688 for an unstated purpose
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
